Literature DB >> 31649156

Role of 3D Pseudocontinuous Arterial Spin-Labeling Perfusion in the Diagnosis and Follow-Up in Patients with Herpes Simplex Encephalitis.

R Li1,2, P-A Shi3, T-F Liu2, Y Li2, Y Wang2, K Wu2, X-J Chen2, H-F Xiao2, Y-L Wang2, L Ma4,2, X Lou2.   

Abstract

BACKGROUND AND
PURPOSE: Early diagnosis and treatment of herpes simplex encephalitis are crucial to reduce morbidity and mortality. Our aim was to investigate the role of 3D pseudocontinuous arterial spin-labeling in herpes simplex encephalitis.
MATERIALS AND METHODS: From 2014 to 2019, seventeen consecutive patients with herpes simplex encephalitis and 15 healthy volunteers were recruited in the study. Conventional MR imaging and 3D pseudocontinuous arterial spin-labeling were performed in all subjects. According to the disease duration, the lesions were classified into 3 groups, including acute, subacute, and chronic stages, respectively. Clinical, neuroradiologic, and follow-up features were studied. The normalized lesion/normal tissue CBF values of lesions at different stages were measured and compared with those in the control group, respectively.
RESULTS: Compared with the control group, herpes simplex encephalitis demonstrated hyperperfusion in 11 acute cases and 6 subacute cases and hypoperfusion in 6 chronic cases. The mean normalized lesion/normal tissue CBF values of the lesions were 2.68 ± 0.54 in the acute stage, 2.42 ± 0.52 in the subacute stage, and 0.87 ± 0.30 in the chronic stage, respectively. The mean normalized lesion/normal tissue CBF values of acute and subacute lesions were significantly higher than those of the control group (1.33 ± 0.08; P < .001, respectively), while the mean normalized lesion/normal tissue CBF values of chronic lesions were lower than those of the control group (P < .05). Gradual perfusion reduction on serial 3D pseudocontinuous arterial spin-labeling was observed in herpes simplex encephalitis after effective therapy.
CONCLUSIONS: Conventional MR imaging remains most helpful in the diagnosis of herpes simplex encephalitis, while 3D pseudocontinuous arterial spin-labeling could be an adjunctive technique by providing dynamic CBF features at different stages in herpes simplex encephalitis.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31649156      PMCID: PMC6975109          DOI: 10.3174/ajnr.A6279

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

1.  CT and MRI findings of human herpesvirus 6-associated encephalopathy: comparison with findings of herpes simplex virus encephalitis.

Authors:  Tomoyuki Noguchi; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yamashita; Eiki Nagao; Akira Uchino; Kanehiro Hasuo; Kazushige Atsumi; Takashi Matsuura; Toshiro Kuroiwa; Futoshi Mihara; Hiroshi Honda; Sho Kudo
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

2.  Perfusion and thallium single photon emission computed tomography in herpes simplex encephalitis.

Authors:  P P De Deyn; P W Van den Broucke; B A Pickut; B Appel; R Crols; P Cras; J J Martin
Journal:  J Neurol Sci       Date:  1998-04-15       Impact factor: 3.181

Review 3.  Applications of arterial spin labeled MRI in the brain.

Authors:  John A Detre; Hengyi Rao; Danny J J Wang; Yu Fen Chen; Ze Wang
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

4.  Delays in initiation of acyclovir therapy in herpes simplex encephalitis.

Authors:  Peter S Hughes; Alan C Jackson
Journal:  Can J Neurol Sci       Date:  2012-09       Impact factor: 2.104

5.  Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells.

Authors:  Ana J Chucair-Elliott; Christopher Conrady; Min Zheng; Chandra M Kroll; Thomas E Lane; Daniel J J Carr
Journal:  Glia       Date:  2014-05-07       Impact factor: 7.452

6.  Viral encephalitis in children: detection with technetium-99m HMPAO brain single-photon emission CT and its value in prediction of outcome.

Authors:  C H Kao; S J Wang; S C Mak; W J Shian; C S Chi
Journal:  AJNR Am J Neuroradiol       Date:  1994-08       Impact factor: 3.825

7.  Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis.

Authors:  Vijay Sawlani
Journal:  J Neurol Sci       Date:  2009-09-03       Impact factor: 3.181

8.  Predictors of outcome in HSV encephalitis.

Authors:  Tarun D Singh; Jennifer E Fugate; Sara Hocker; Eelco F M Wijdicks; Allen J Aksamit; Alejandro A Rabinstein
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

Review 9.  Perfusion MRI: the five most frequently asked clinical questions.

Authors:  Marco Essig; Thanh Binh Nguyen; Mark S Shiroishi; Marc Saake; James M Provenzale; David S Enterline; Nicoletta Anzalone; Arnd Dörfler; Àlex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

Review 10.  Viral encephalitis: a clinician's guide.

Authors:  Tom Solomon; Ian J Hart; Nicholas J Beeching
Journal:  Pract Neurol       Date:  2007-10
View more
  3 in total

Review 1.  Brain Perfusion Alterations on 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in Patients with Autoimmune Encephalitis: A Case Series and Literature Review.

Authors:  R Li; S Jin; Y Wang; J-F Li; H-F Xiao; Y-L Wang; L Ma
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-07       Impact factor: 3.825

2.  Regarding "Brain Perfusion Alterations on 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in Patients with Autoimmune Encephalitis: A Case Series and Literature Review".

Authors:  X Zhang; D Zheng; Q Huang
Journal:  AJNR Am J Neuroradiol       Date:  2022-08-25       Impact factor: 4.966

3.  Epileptic seizures in the emergency room: clinical and electroencephalographic findings associated with brain perfusion patterns on computed tomography.

Authors:  J L Restrepo-Vera; P Coscojuela; E Fonseca; M Quintana; S Sarria-Estrada; E Santamarina; L Abraira; M Sueiras; V Thonon; J Álvarez-Sabin; M Toledo; A Rovira
Journal:  J Neurol       Date:  2022-02-13       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.